Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Andree Kurniawan
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 6, pp. 1662-1670
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells
Ahmed Bakillah, Fatimah Al Hejji, Abdulrahman Almasaud, et al.
Nutrients (2022) Vol. 14, Iss. 16, pp. 3417-3417
Open Access | Times Cited: 39
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis
Αναστάσιος Κόλλιας, Konstantinos G. Kyriakoulis, Ioannis Kyriakoulis, et al.
Atherosclerosis (2021) Vol. 330, pp. 114-121
Open Access | Times Cited: 53
Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis
Amir Vahedian‐Azimi, Seyede Momeneh Mohammadi, Maciej Banach, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 53
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, et al.
Diabetes Research and Clinical Practice (2021) Vol. 179, pp. 109031-109031
Open Access | Times Cited: 52
The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis
Kuan‐Sheng Wu, Pei‐Chin Lin, Yao-Shen Chen, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 874-884
Open Access | Times Cited: 42
Magnetic Resonance Spectroscopy of Traumatic Brain Injury and Subconcussive Hits: A Systematic Review and Meta–Analysis
Julie M. Joyce, Parker La, Robyn Walker, et al.
Journal of Neurotrauma (2022) Vol. 39, Iss. 21-22, pp. 1455-1476
Open Access | Times Cited: 34
Coronavirus disease 2019 (Covid-19) outcomes in patients with sarcopenia: A meta-analysis and meta-regression
Yusak Mangara Tua Siahaan, Vinson Hartoyo, Timotius Ivan Hariyanto, et al.
Clinical Nutrition ESPEN (2022) Vol. 48, pp. 158-166
Open Access | Times Cited: 33
The Effect of Prior Use of Statins on the Severity of COVID-19 Disease
Hadi Hasani, Farzaneh Hamidi, Fatemeh Ahmadi-Forg, et al.
Critical Care Nursing Quarterly (2025) Vol. 48, Iss. 2, pp. 143-150
Closed Access
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Stanisław Surma, Maciej Banach, Joanna Lewek
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19
Álvaro Aparisi, Carolina Iglesias-Echeverría, Cristina Ybarra-Falcón, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 9, pp. 2619-2627
Open Access | Times Cited: 35
HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study
Rita Bergqvist, Viktor H. Ahlqvist, Michael Lundberg, et al.
PLoS Medicine (2021) Vol. 18, Iss. 10, pp. e1003820-e1003820
Open Access | Times Cited: 34
Acute Respiratory Distress Syndrome and COVID-19: A Literature Review
Musaddique Hussain, Shahzada Khurram Syed, Mobeen Fatima, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 7225-7242
Open Access | Times Cited: 34
Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
Kim Bouillon, Bérangère Baricault, Laura Semenzato, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 19
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital
Fumiki Yoshihara, Yasushi Matsuzawa, Kiyomasa Nakatsuka, et al.
Hypertension Research (2024) Vol. 47, Iss. 7, pp. 1943-1951
Closed Access | Times Cited: 3
Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study
Juhyun Song, Dae Won Park, Jaehyung Cha, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 21
Efficacy of Statin Therapy in Patients with Hospital Admission for COVID-19
Daein Choi, Qinzhong Chen, Sascha N. Goonewardena, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 36, Iss. 6, pp. 1165-1173
Open Access | Times Cited: 17
EXPRESS: Short-term Efficacy of Moderate Intensity Rosuvastatin in COVID-19 Patients: A Randomized Clinical Trial
Katayoun Rafsanjani, Amirhossein Ghaseminejad‐Raeini, Alireza Azarboo, et al.
Journal of Investigative Medicine (2024) Vol. 73, Iss. 1, pp. 85-93
Closed Access | Times Cited: 1
All-cause mortality in COVID-19 patients receiving statin therapy: analysis of veterans affairs database cohort study
Ali El-Solh, Yolanda Lawson, Daniel A. El-Solh
Internal and Emergency Medicine (2021) Vol. 17, Iss. 3, pp. 685-694
Open Access | Times Cited: 12
Effect of diabetes on short-term mortality and incidence of first hospitalizations for cardiovascular events after recovery from SARS-CoV-2 infection
Francesco Profili, Giuseppe Seghieri, Paolo Francesconi
Diabetes Research and Clinical Practice (2022) Vol. 187, pp. 109872-109872
Open Access | Times Cited: 8
Why antidiabetic drugs are potentially neuroprotective during the Sars-CoV-2 pandemic: The focus on astroglial UPR and calcium-binding proteins
Carlos‐Alberto Gonçalves, Patrícia Sesterheim, Krista Minéia Wartchow, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 8
Outpatient atorvastatin use and severe COVID‐19 outcomes: A population‐based study
Irene Visos‐Varela, Maruxa Zapata‐Cachafeiro, Samuel Pintos‐Rodríguez, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 4
Cardiovascular, cerebrovascular, and renal co-morbidities in COVID-19 patients: A systematic-review and meta-analysis
Abby C. Lee, Wei Tse Li, Lauren Apostol, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 3755-3764
Open Access | Times Cited: 11
Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study
Pandora L. Wander, Elliott Lowy, Lauren A. Beste, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e058363-e058363
Open Access | Times Cited: 7
Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19
Yiran Rong, Swarnali Goswami, O Eriakha, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e076195-e076195
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top